Cargando…
1791. The Impact of a β-lactam Allergy Assessment on Aztreonam Utilization Within a Healthcare System
BACKGROUND: Penicillin allergies are the most commonly reported drug allergies and are documented in up to 17% of patients. Incomplete reaction histories and exaggerated concerns regarding the risk of cross-reactivity often leads to unnecessary avoidance of β-lactams in patients with reported allerg...
Autores principales: | Shea, Katherine, Knight, Tamara, Jaso, Theresa, Bissett, Jack, Moser, M Tanner, Hobbs, Athena L V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253655/ http://dx.doi.org/10.1093/ofid/ofy210.1447 |
Ejemplares similares
-
965. The Efficacy of Oral Β-lactam Antibiotics as Step-down Therapy for Acute Pyelonephritis
por: Hobbs, Athena L V, et al.
Publicado: (2019) -
Nonirritating skin test concentrations for ceftazidime and aztreonam in patients with a documented beta-lactam allergy
por: van der Poorten, Marie-Line M., et al.
Publicado: (2021) -
239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020) -
Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections
por: Hogan, Michael, et al.
Publicado: (2018) -
1601. Evaluation of Synergy with β-Lactams Plus Aztreonam Against Pseudomonas aeruginosa (PSA)
por: O’Donnell, J Nicholas, et al.
Publicado: (2019)